 | • レポートコード：QYR9N7361 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、炎症性腸疾患（IBD）治療学のグローバル市場について調査・分析したレポートで、種類別（抗炎症バイオ医薬品、非ステロイド系抗炎症薬（NSAID）、コルチコステロイド）、用途別（病院、研究）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・炎症性腸疾患（IBD）治療学の世界市場規模 ・主要企業別市場シェア ・炎症性腸疾患（IBD）治療学の世界市場規模：種類別（抗炎症バイオ医薬品、非ステロイド系抗炎症薬（NSAID）、コルチコステロイド） ・炎症性腸疾患（IBD）治療学の世界市場規模：用途別（病院、研究） ・炎症性腸疾患（IBD）治療学のアメリカ市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学のヨーロッパ市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学の中国市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学の日本市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学の東南アジア市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学のインド市場規模（種類別、用途別） ・炎症性腸疾患（IBD）治療学の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・炎症性腸疾患（IBD）治療学の世界市場予測（2019年-2025年） ・炎症性腸疾患（IBD）治療学の地域別市場予測（2019年-2025年） ... |
Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market. In addition, strong upcoming pipeline of IBD drugs also boosts the market growth. However, side effects of these drugs over a patients body restrain the market growth. Development of biosimilars for existing drugs, and growth opportunities in the emerging economies of Asia-Pacific and LAMEA provide opportunities for the market growth.
In 2018, the global Inflammatory Bowel Disease (IBD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Inflammatory Bowel Disease (IBD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease (IBD) Therapeutics development in United States, Europe and China.
The key players covered in this study
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Celgene
Pfizer
Salix
Roche
Teva Pharmaceutical
Market segment by Type, the product can be split into
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
Market segment by Application, split into
Hospital
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Inflammatory Bowel Disease (IBD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease (IBD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Inflammatory Bowel Disease (IBD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-inflammatory Biologics
1.4.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.4.4 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size
2.2 Inflammatory Bowel Disease (IBD) Therapeutics Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Manufacturers
3.1.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease (IBD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease (IBD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
5.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in United States
5.3 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
5.4 United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
6 Europe
6.1 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
6.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Europe
6.3 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
6.4 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
7 China
7.1 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
7.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in China
7.3 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
7.4 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
8 Japan
8.1 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
8.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Japan
8.3 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
8.4 Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
9.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
10 India
10.1 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
10.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in India
10.3 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
10.4 India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
11.2 Inflammatory Bowel Disease (IBD) Therapeutics Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application
12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.1.4 Abbvie Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.4.4 Merck Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.5.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Celgene
12.6.1 Celgene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.6.4 Celgene Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.6.5 Celgene Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.7.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Salix
12.8.1 Salix Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.8.4 Salix Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.8.5 Salix Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.9.4 Roche Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.9.5 Roche Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Inflammatory Bowel Disease (IBD) Therapeutics Introduction
12.10.4 Teva Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Inflammatory Bowel Disease (IBD) Therapeutics Key Market Segments
Table Key Players Inflammatory Bowel Disease (IBD) Therapeutics Covered
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-inflammatory Biologics Figures
Table Key Players of Anti-inflammatory Biologics
Figure Non-Steroidal Anti-inflammatory drugs (NSAIDs) Figures
Table Key Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Research Case Studies
Figure Inflammatory Bowel Disease (IBD) Therapeutics Report Years Considered
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Manufacturers in 2018
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Bowel Disease (IBD) Therapeutics Product/Solution/Service
Table Date of Enter into Inflammatory Bowel Disease (IBD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Revenue Market Share by Application in 2018
Figure United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table China Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure India Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table India Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease (IBD) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease (IBD) Therapeutics Market Share (2018-2019)
Table Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application (2014-2019)
Table Abbvie Company Details
Table Abbvie Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019) (Million US$)
Figure Abbvie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Abbvie Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Celgene Company Details
Table Celgene Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Celgene Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Salix Company Details
Table Salix Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Salix Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Salix Recent Development
Table Roche Company Details
Table Roche Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Regions in 2025
Figure United States Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Product (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Product in 2025
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測 Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…- 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の炎症性心疾患市場：市場規模・現状・予測 Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment.Changing lifestyle resulting in higher prevalence of viral and fu…
- 世界のまれな炎症性疾患の治療市場：市場規模・現状・予測 In 2018, the global Rare Inflammatory Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rare Inflammatory Disease Treatment status, future forecast, growth opportunity…
- 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …